185 related articles for article (PubMed ID: 16357137)
1. FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.
Kumar R; Neilsen PM; Crawford J; McKirdy R; Lee J; Powell JA; Saif Z; Martin JM; Lombaerts M; Cornelisse CJ; Cleton-Jansen AM; Callen DF
Cancer Res; 2005 Dec; 65(24):11304-13. PubMed ID: 16357137
[TBL] [Abstract][Full Text] [Related]
2. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
[TBL] [Abstract][Full Text] [Related]
3. Functional identification of a BAC clone from 16q24 carrying a senescence gene SEN16 for breast cancer cells.
Kaur GP; Reddy DE; Zimonjic DB; de Riel JK; Athwal RS
Oncogene; 2005 Jan; 24(1):47-54. PubMed ID: 15558027
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
Bilanges B; Varrault A; Basyuk E; Rodriguez C; Mazumdar A; Pantaloni C; Bockaert J; Theillet C; Spengler D; Journot L
Oncogene; 1999 Jul; 18(27):3979-88. PubMed ID: 10435621
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
6. SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer.
Zeller C; Hinzmann B; Seitz S; Prokoph H; Burkhard-Goettges E; Fischer J; Jandrig B; Schwarz LE; Rosenthal A; Scherneck S
Oncogene; 2003 May; 22(19):2972-83. PubMed ID: 12771949
[TBL] [Abstract][Full Text] [Related]
7. FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma.
Huang HL; Zheng WL; Zhao R; Zhang B; Ma WL
Oncol Rep; 2010 Sep; 24(3):715-20. PubMed ID: 20664978
[TBL] [Abstract][Full Text] [Related]
8. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.
Bednarek AK; Keck-Waggoner CL; Daniel RL; Laflin KJ; Bergsagel PL; Kiguchi K; Brenner AJ; Aldaz CM
Cancer Res; 2001 Nov; 61(22):8068-73. PubMed ID: 11719429
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer.
Radke S; Pirkmaier A; Germain D
Oncogene; 2005 May; 24(21):3448-58. PubMed ID: 15782142
[TBL] [Abstract][Full Text] [Related]
10. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
11. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage.
Santra MK; Wajapeyee N; Green MR
Nature; 2009 Jun; 459(7247):722-5. PubMed ID: 19412162
[TBL] [Abstract][Full Text] [Related]
12. A candidate tumor suppressor gene in human breast cancers.
Schott DR; Chang JN; Deng G; Kurisu W; Kuo WL; Gray J; Smith HS
Cancer Res; 1994 Mar; 54(6):1393-6. PubMed ID: 8137235
[TBL] [Abstract][Full Text] [Related]
13. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
15. The SCF
Choppara S; Ganga S; Manne R; Dutta P; Singh S; Santra MK
J Biol Chem; 2018 Oct; 293(42):16291-16306. PubMed ID: 30171069
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor FBXO31 preserves genomic integrity by regulating DNA replication and segregation through precise control of cyclin A levels.
Dutta P; Islam S; Choppara S; Sengupta P; Kumar A; Kumar A; Wani MR; Chatterjee S; Santra MK
J Biol Chem; 2019 Oct; 294(41):14879-14895. PubMed ID: 31413110
[TBL] [Abstract][Full Text] [Related]
17. FBXO31 determines poor prognosis in esophageal squamous cell carcinoma.
Kogo R; Mimori K; Tanaka F; Komune S; Mori M
Int J Oncol; 2011 Jul; 39(1):155-9. PubMed ID: 21537837
[TBL] [Abstract][Full Text] [Related]
18. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
[TBL] [Abstract][Full Text] [Related]
19. SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication.
Johansson P; Jeffery J; Al-Ejeh F; Schulz RB; Callen DF; Kumar R; Khanna KK
J Biol Chem; 2014 Jun; 289(26):18514-25. PubMed ID: 24828503
[TBL] [Abstract][Full Text] [Related]
20. Constitutive expression of Rb associated protein 46 (RbAp46) reverts transformed phenotypes of breast cancer cells.
Zhang TF; Yu SQ; Deuel TF; Wang ZY
Anticancer Res; 2003; 23(5A):3735-40. PubMed ID: 14666671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
